Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revvity, Inc. Common Stock (NY:RVTY)

107.34 -0.02 (-0.02%)
Official Closing Price Updated: 7:00 PM EDT, Mar 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 614,036
Open 107.16
Bid (Size) 105.51 (1)
Ask (Size) 125.85 (1)
Prev. Close 107.36
Today's Range 106.29 - 108.49
52wk Range 97.31 - 129.50
Shares Outstanding N/A
Dividend Yield 0.26%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Revvity Gaining or Losing Market Support?
Via Benzinga
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs. 
Via Investor's Business Daily
Topics Government
Exposures Political

Performance

YTD
-4.2%
-4.2%
1 Month
-7.1%
-7.1%
3 Month
-4.6%
-4.6%
6 Month
-15.0%
-15.0%
1 Year
+1.8%
+1.8%

More News

Read More
Maryland Rep. April McClain Delaney Sold Over $54K Worth of A.O. Smith Stock: Here's What You Should Know
Via Benzinga
Stay informed with the top movers within the S&P500 index on Wednesday.
Via Chartmill
What Does the Market Think About Revvity?
Via Benzinga
(RVTY) - Analyzing Revvity's Short Interest
Via Benzinga
Forecasting The Future: 7 Analyst Projections For Revvity
Via Benzinga
Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England
From Revvity
Via Business Wire
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
Which S&P500 stocks are gapping on Wednesday?
Via Chartmill
Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay
From Revvity
Via Business Wire
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
Via StockStory
Topics Economy
Exposures Supply Chain
3 Reasons to Sell RVTY and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
Exposures US Equities
Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group
From Revvity
Via Business Wire
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations
Via StockStory
Friday's pre-market session: top gainers and losers in the S&P500 index
Via Chartmill
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024
From Revvity
Via Business Wire
Earnings Scheduled For January 31, 2025
Via Benzinga
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
From Revvity
Via Business Wire
Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance
From Revvity
Via Business Wire
Revvity Announces FDA Clearance for First Automated Free Testosterone Test
From Revvity
Via Business Wire
Revvity to Present at J.P. Morgan Healthcare Conference
From Revvity
Via Business Wire

Frequently Asked Questions

Is Revvity, Inc. Common Stock publicly traded?
Yes, Revvity, Inc. Common Stock is publicly traded.
What exchange does Revvity, Inc. Common Stock trade on?
Revvity, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Revvity, Inc. Common Stock?
The ticker symbol for Revvity, Inc. Common Stock is RVTY on the New York Stock Exchange
What is the current price of Revvity, Inc. Common Stock?
The current price of Revvity, Inc. Common Stock is 107.34
When was Revvity, Inc. Common Stock last traded?
The last trade of Revvity, Inc. Common Stock was at 03/27/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.